Fluticasone-salmeterol 115-21 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26FL015
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,656
Award facts
- Contract value 100% obligated
- $14,656.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,656.19 to AmerisourceBergen Drug Corp for the supply of Fluticasone-Salmeterol 115-21 12GM inhalation medication. This is a firm fixed-price, non-set-aside contract awarded competitively on January 22, 2026, with an ultimate completion date of January 23, 2026. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen).
This delivery order represents a routine pharmaceutical procurement supporting military medical supply chain operations. AmerisourceBergen maintains an extensive portfolio of federal contracts with the DLA and other defense health agencies, demonstrating its critical role as a major pharmaceutical distributor for federal medical procurement. The underlying indefinite delivery contract encompasses a broad range of medical commodities including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling rapid fulfillment of evolving military healthcare requirements through a flexible contracting vehicle.
Quick answers
Who was awarded contract SPE2DR26FL015?
SPE2DR26FL015 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FL015 worth?
The government has obligated $14,656 on SPE2DR26FL015.
Is contract SPE2DR26FL015 an order under another contract?
Yes. SPE2DR26FL015 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL015 competed?
The extent of competition for SPE2DR26FL015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award